MedTrace Logo

External Ventricular Drainage Post-Market Clinical Follow-up Registry

NCT05652296 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 120

Last updated 2026-01-28

Study results available
· View outcomes & findings →

Summary

This post-market follow-up registry will capture clinical data specific to the safety and performance of the Integra External Ventricular Drainage Systems and Accessories.

Conditions

  • Cerebrospinal; Disorder

Interventions

DEVICE

External Ventricular Drainage (EVD)

EVD of Cerebral Spinal Fluid from the lateral ventricles of the brain

Sponsors & Collaborators

  • Integra LifeSciences Corporation

    lead INDUSTRY

Principal Investigators

  • Jason Marzuola · Integra LifeSciences Corporation

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-03-03
Primary Completion
2024-12-16
Completion
2024-12-16

Countries

  • Belgium
  • France

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05652296 on ClinicalTrials.gov